CHNXF vs REGN: Which Stock is Better?
Side-by-side comparison of ChitogenX Inc. and Regeneron Pharmaceuticals Inc in 2026
CHNXF
ChitogenX Inc.
$0.01
REGN
Regeneron Pharmaceuticals Inc
$750.57
Key Metrics Comparison
| Metric | CHNXF | REGN | Winner |
|---|---|---|---|
| Market Cap | $0.63M | $79.35B | REGN |
| P/E Ratio | N/A | 18.08 | REGN |
| EPS (TTM) | $N/A | $41.51 | REGN |
| Revenue Growth | 0.0% | 0.0% | REGN |
| Gross Margin | 0.0% | 44.6% | REGN |
Analyze CHNXF
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CHNXF or REGN a better investment?
Comparing CHNXF and REGN: ChitogenX Inc. has a market cap of $0.63M while Regeneron Pharmaceuticals Inc has $79.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CHNXF and REGN?
CHNXF (ChitogenX Inc.) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CHNXF or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CHNXF or REGN?
REGN has higher revenue growth at 0.0% vs 0.0% for CHNXF.
Which company is more profitable: CHNXF or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to 0.0% for CHNXF.
Which is the larger company: CHNXF or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.35B compared to $0.63M for CHNXF.
Should I buy CHNXF or REGN in 2026?
Both CHNXF and REGN have investment merit. CHNXF trades at $0.01 while REGN trades at $750.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CHNXF and REGN stock?
Key differences: Market Cap ($0.63M vs $79.35B), P/E Ratio (N/A vs 18.1x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 44.6%).